CPT code 0627T defines an image-guided intradiscal procedure in which a cellular or tissue–based product is injected into a lumbar intervertebral disc under fluoroscopic guidance. This code covers the first lumbar level treated and can represent a unilateral or bilateral injection. The code is notable nationally as regenerative and biologic intradiscal therapies expand and attract payer attention for coverage policy, coding guidance, and utilization oversight.

Key payers in the national analysis include Aetna, Blue Cross Blue Shield plans, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical procedure context, common billing considerations, and payer coverage framing. The publication summarizes available benchmarks where present, highlights relevant policy and coding updates impacting reimbursement and prior authorization, and situates 0627T within outpatient interventional spine service lines.

This summary is intended to inform billing managers, coding professionals, and policy analysts about the clinical purpose of the code, typical sites of service, and the payer landscape. Data not available in the input is noted where applicable in subsequent sections.